Literature DB >> 2330337

Stimulation of low density lipoprotein receptor activity in liver membrane of guggulsterone treated rats.

V Singh1, S Kaul, R Chander, N K Kapoor.   

Abstract

Chronic feeding of guggulsterone to rats showed hypolipidaemic activity in blood serum and liver membrane lipids. The decrease in serum cholesterol is associated with enhanced uptake of LDL by the liver through receptor mediated endocytosis, located on the surface of the cell membrane. In the present communication it has been shown that membranes prepared from liver of guggulsterone treated rats exhibit up to 87% increase in binding sites for human 125I-LDL. Significant decrease in lipid levels of serum as well as of membrane were observed. Lipid lowering activity of the drug in relation to LDL catabolism and other possible mechanisms have been explained.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330337     DOI: 10.1016/1043-6618(90)90741-u

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

Review 1.  Pregnane X receptor and natural products: beyond drug-drug interactions.

Authors:  Jeff L Staudinger; Xunshan Ding; Kristin Lichti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

2.  Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice.

Authors:  Andrea Leiva; Susana Contreras-Duarte; Ludwig Amigo; Esteban Sepúlveda; Mauricio Boric; Verónica Quiñones; Dolores Busso; Attilio Rigotti
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

3.  Acute toxicity and antihyperlipidemic activity of rhizome of Tectaria coadunata (Kukkutnakhi): A folklore herb.

Authors:  Hardik Mori; K Nishteswar; B R Patel; Mukesh Nariya
Journal:  Ayu       Date:  2016 Jul-Dec

Review 4.  Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Authors:  Ajaikumar B Kunnumakkara; Kishore Banik; Devivasha Bordoloi; Choudhary Harsha; Bethsebie L Sailo; Ganesan Padmavathi; Nand K Roy; Subash C Gupta; Bharat B Aggarwal
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

5.  Polysaccharide from fuzi (FPS) prevents hypercholesterolemia in rats.

Authors:  Xiongqing Huang; Juan Tang; Qin Zhou; Hanping Lu; Yiling Wu; Weikang Wu
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.